About
Orphan inflammatory-fibrotic diseases
Areas of Focus
Categories
Small Molecule PharmaceuticalCannabis & MarijuanaBoston & New England
Team (6)
Christina Bertsch. M.A.
Corbus Pharmaceuticals
team_member
Dr. Dominic Smethurst, MA MRCP
Corbus Pharmaceuticals
team_member
G. Scott Goeken, M.S., J.D.
Corbus Pharmaceuticals
team_member
Ian Hodgson, BSc (Hons), Ph. D.
Corbus Pharmaceuticals
team_member
Sean Moran, CPA, MBA
Corbus Pharmaceuticals
team_member
Yuval Cohen, Ph.D.
Corbus Pharmaceuticals
team_member
Clinical Trials (9)
View allTotal Trials
9
As Lead Sponsor
8
As Collaborator
1
Total Enrollment
1,750
By Phase
PHASE1/PHASE2: 2PHASE3: 2PHASE2: 5
By Status
COMPLETED: 4TERMINATED: 3RECRUITING: 2
Clinical Trials Pipeline9 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06603844Lead Sponsor
First-in-human Study of CRB-601-01 to Treat Patients With Advanced Solid Tumor.
PHASE1/PHASE2Recruiting
156 participants
Started: Dec 4, 2024 · Completed: Dec 1, 2026
NCT06265727Lead Sponsor
A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
PHASE1/PHASE2Recruiting
348 participants
Started: Apr 1, 2024 · Completed: Jan 27, 2027
NCT03813160Lead Sponsor
Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis
PHASE3Completed
176 participants
Started: Dec 17, 2018 · Completed: Oct 5, 2021
NCT03451045Lead Sponsor
Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis
PHASE2Completed
447 participants
Started: Dec 22, 2017 · Completed: Jun 17, 2020
NCT03093402Collaborator
JBT-101 in Systemic Lupus Erythematosus (SLE)
PHASE2Completed
109 participants
Started: Dec 21, 2017 · Completed: Jul 28, 2021
Locations (1)
Headquarters
Norwood, MA, United States
Map
Loading map...